Vyne Therapeutics Stock Forecast - Price Action Indicator

VYNE Stock  USD 2.30  0.10  4.17%   
Vyne Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Vyne Therapeutics stock prices and determine the direction of Vyne Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Vyne Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Vyne Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Vyne Therapeutics' systematic risk associated with finding meaningful patterns of Vyne Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Vyne Therapeutics to cross-verify your projections.
For information on how to trade Vyne Stock refer to our How to Trade Vyne Stock guide.
  
As of April 19, 2024, Inventory Turnover is expected to decline to 0.24. In addition to that, Payables Turnover is expected to decline to 0.24. The current year's Common Stock Shares Outstanding is expected to grow to about 10.8 M, whereas Net Loss is forecasted to decline to (21.9 M).
Vyne Therapeutics has current Price Action Indicator of (0.07).
Most investors in Vyne Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Vyne Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Vyne Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.
Check Vyne Therapeutics VolatilityBacktest Vyne TherapeuticsInformation Ratio  

Vyne Therapeutics Trading Date Momentum

On April 19 2024 Vyne Therapeutics was traded for  2.30  at the closing time. The top price for the day was 2.39  and the lowest listed price was  2.25 . There was no trading activity during the period 0.0. Lack of trading volume on April 19, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 3.91% .
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Vyne Therapeutics to competition

Other Forecasting Options for Vyne Therapeutics

For every potential investor in Vyne, whether a beginner or expert, Vyne Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Vyne Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Vyne. Basic forecasting techniques help filter out the noise by identifying Vyne Therapeutics' price trends.

View Vyne Therapeutics Related Equities

 Risk & Return  Correlation

Vyne Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Vyne Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Vyne Therapeutics' current price.

Vyne Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Vyne Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vyne Therapeutics shares will generate the highest return on investment. By undertsting and applying Vyne Therapeutics stock market strength indicators, traders can identify Vyne Therapeutics entry and exit signals to maximize returns.

Vyne Therapeutics Risk Indicators

The analysis of Vyne Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Vyne Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting vyne stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Vyne Therapeutics is a strong investment it is important to analyze Vyne Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vyne Therapeutics' future performance. For an informed investment choice regarding Vyne Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Vyne Therapeutics to cross-verify your projections.
For information on how to trade Vyne Stock refer to our How to Trade Vyne Stock guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Vyne Stock analysis

When running Vyne Therapeutics' price analysis, check to measure Vyne Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vyne Therapeutics is operating at the current time. Most of Vyne Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vyne Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vyne Therapeutics' price. Additionally, you may evaluate how the addition of Vyne Therapeutics to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Is Vyne Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vyne Therapeutics. If investors know Vyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.72)
Revenue Per Share
0.041
Quarterly Revenue Growth
11.667
Return On Assets
(0.26)
Return On Equity
(0.46)
The market value of Vyne Therapeutics is measured differently than its book value, which is the value of Vyne that is recorded on the company's balance sheet. Investors also form their own opinion of Vyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Vyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vyne Therapeutics' market value can be influenced by many factors that don't directly affect Vyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.